JOHN NOVAK: Open Payments
NPI 1306807292 · COLUMBIA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,532 in 77 payments from 21 companies in 2025. Trend: 2023 $1,065 · 2024 $1,141 · 2025 $1,532
Food & beverage: $1,532
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $412 |
| PFIZER INC. | 12 | $164 |
| Novo Nordisk Inc | 11 | $163 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $103 |
| Lilly USA, LLC | 6 | $100 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $69 |
| Xeris Pharmaceuticals, Inc. | 3 | $64 |
| Corcept Therapeutics | 3 | $63 |
| ACADIA Pharmaceuticals Inc | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $44 |
Products named: VRAYLAR, QULIPTA, Kerendia, UBRELVY, Ozempic, XIFAXAN, MOUNJARO, GVOKE HYPOPEN.
Industry payments across TN — which companies pay providers there.
